Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Health Holland | OTHER |
Not provided
Not provided
Not provided
Rapid diagnosis of sepsis is crucial for treatment and survival. Currently, blood culture takes 48 hours-5 days to complete. After starting antimicrobial treatment blood culture results are not reliable. As a result, empirical broad spectrum antimicrobial therapy is mostly used. This implies possible antimicrobial over- or under treatment which is associated with increased antimicrobial resistance development. Early identification of the causative pathogen of sepsis will therefore have a major impact on the adequate treatment and reduction of high mortality rates. To date, there is not a single molecular diagnostic test available on the market to detect all putative causative bacterial pathogens of sepsis. In this study, the investigators will develop and validate a completely new molecular sepsis approach based on pathogen DNA detection, as an alternative to culture.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Development and validation of rapid diagnostics tests for detection of bacterial DNA in sepsis | The tests will report presence of bacterial DNA by giving a specific bacterial species name. | 2 years |
| Patterns of bacterial DNA dynamics over time | Use of species-specific qPCR primers (either from existing sepsis literature or to be designed) to quantify the DNA load at at least 3 different time points during an infectious episode. Comparison of these loads with infectious parameters used for routine diagnostics and with antibiotic use. | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Distinguishing between the causative pathogen and contamination by a physician evaluation panel, both for the current gold standard (blood cultures) and the results of new microbiological tests for detecting sepsis pathogens | 2 years |
Not provided
Inclusion Criteria:
-Patients are included when routine blood cultures are ordered for diagnosis of bloodstream infections.
Exclusion Criteria:
-N/A
Not provided
Not provided
Not provided
Patients at the Intensive Care Unit (ICU) of Maastricht University Medical Center (MUMC) are eligible.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Anna Wijen, Msc. | Contact | +31 626882868 | anna.wijen@maastrichtuniversity.nl | |
| Paul Savelkoul, Prof. Dr. | Contact | +31 433876610 | paul.savelkoul@mumc.nl |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Maastricht University Medical Center | Recruiting | Maastricht | Limburg | 6229 HX | Netherlands |
Not provided
| ID | Term |
|---|---|
| D018805 | Sepsis |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Lysed whole blood samples from which microbial DNA has been isolated
| D013568 |
| Pathological Conditions, Signs and Symptoms |